Continuing metformin when introducing sulfonylureas is safer than switching in T2DM, research shows
Switching to sulfonylureas increases the risk of serious adverse events compared with remaining on metformin in people with type 2 diabetes mellitus, according to research published in The BMJ.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Fortamet | Metformin